Prevention of Respiratory Syncytial Virus–Related Hospitalization in Newborns—Reply
In Reply We appreciate the opportunity to respond to comments by Dr Manzoni and colleagues about our study comparing passive infant immunization with nirsevimab and maternal immunization with the RSVpreF vaccine for the prevention of RSV-related hospitalization in newborns.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.